FuGENE 6 Transfection Reagent: the gentle power.

Methods

Roche Applied Science, Roche Diagnostics Corporation, 9115 Hague Road, Indianapolis, IN 46250-0414, USA.

Published: June 2004

FuGENE 6 Transfection Reagent has been commercially available since 1997. Since that time, its popularity has increased due to its ease of use, minimal to no cytotoxicity, and the high level of transfection in many different cell lines. FuGENE 6 Transfection Reagent is gentle on the cells. Adherent cells can be trypsinized and transfected by the DNA:FuGENE 6 reagent complex prior to plating, making it a strong candidate for high throughput applications. Additionally, low cell numbers can be transfected in 96-well plates. As with most reagents, the complex formation step is critical and special handling is required because the reagent is supplied in 80% ethanol. For example, contact with plastic must be avoided as inhibitors of transfection can leach from some plastics. We investigated parameters that have been reported to affect the transfection efficiency including the use of common antibiotics, passage level of the cells, and length of time for complex formation. These parameters are often cell line dependent and can be optimized to increase transfection efficiency for a specific cell line.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymeth.2003.11.002DOI Listing

Publication Analysis

Top Keywords

fugene transfection
12
transfection reagent
12
reagent gentle
8
complex formation
8
transfection efficiency
8
transfection
6
reagent
5
gentle power
4
power fugene
4
reagent commercially
4

Similar Publications

Charge-neutralized polyethylenimine-lipid nanoparticles for gene transfer to human embryonic stem cells.

Bioorg Med Chem

November 2024

Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, 300072, China; School of Biomedical Engineering and Technology, Tianjin Medical University, Tianjin, 300070, China. Electronic address:

Article Synopsis
  • Gene delivery is essential for modifying stem cells, and this study introduces a new method for creating charge-neutralized polyethylenimine (PEI)-lipid nanoparticles aimed at improving stem cell transfection.
  • The research shows that over 15% of these nanoparticles achieved high transfection efficiency across different cell types, outperforming popular methods like Lipofectamine 2000 and FuGENE HD.
  • Key factors for efficient gene delivery were identified, including the length and ratio of hydrophobic alkyl substitutions, leading to better results than conventional cationic PEI and enabling the successful transfer of two plasmid DNAs into challenging human embryonic stem cells for optogenetic research.
View Article and Find Full Text PDF

Transfection is a potent technique to introduce foreign nucleic acids into eukaryotic cells. The capacity of the technique to alter the genetic content of host cells means it is useful for a wide range of applications, including the study of typical cellular processes, disease molecular mechanisms, and gene therapy effects. Here, we discuss a highly reliable and fully automated transient transfection protocol that utilizes an open-source liquid handler and accompanying HEPA Module.

View Article and Find Full Text PDF

Leveraging liposomes for drug and nucleic acid delivery, though promising due to reduced toxicity and ease of preparation, faces challenges in stability and efficiency. To address this, we synthesized cationic amphiphiles from amino acids (arginine, lysine, and histidine). Histidine emerged as the superior candidate, leading to the development of three histidine-rich cationic amphiphiles for liposomes.

View Article and Find Full Text PDF

Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture.

J Virol Methods

April 2024

Department of Life Sciences, College of Health, Medicine & Life Sciences, Brunel University London, Uxbridge, UK; Division of Ecology and Evolution, Department of Life Sciences, Imperial College London, London, UK; Testavec Ltd, Queensgate House, Maidenhead, UK. Electronic address:

HIV-1 based lentiviral viruses are considered powerful and versatile gene therapy vectors to deliver therapeutic genes to patients with hereditary or acquired diseases. These vectors can efficiently transduce a variety of cell types when dividing or non-dividing to provide permanent delivery and long-term gene expression. Demand for scalable manufacturing protocols able to generate enough high titre vector for widespread use of this technology is increasing and considerable efforts to improve vector production cost-effectively, is ongoing.

View Article and Find Full Text PDF

Back to basics: Optimization of DNA and RNA transfer in muscle cells using recent transfection reagents.

Exp Cell Res

December 2022

Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, 1 Rue Michel Servet, 1211, Geneva, Switzerland. Electronic address:

C2C12 cells are widely used in the muscle field, as they differentiate easily into myotubes and show limited constraints to culture as compared to primary myoblasts. Both C2C12 and primary myoblasts are hard to transfect, which affects downstream experiments. More than 95% of the reports published since 2015 with C2C12 cells have used one gold standard transfectant (i.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!